Dr. M. William Audeh is a medical oncologist specializing in breast cancer, with over 30 years of experience as a clinician and clinical researcher at the Cedars-Sinai Cancer Center in Los Angeles, where he continues to be a member of the Medical Staff. He has been the Chief Medical Officer for Agendia, a precision oncology company providing genomic profiling of early breast cancer, since 2016. During his years of clinical practice at Cedars-Sinai, Dr. Audeh served as Director of the Cedars-Sinai Cancer Center, Clinical Chief of the Division of Hematology/Oncology, Chair of the Cancer Committee, Medical Director of the Wasserman Breast Cancer Risk Reduction Program and faculty member in the Cedars-Sinai Biomedical PhD program and Breast Surgery and Surgical Oncology Fellowships at Cedars-Sinai. He has had an academic appointment as Associate Clinical Professor of Medicine at the UCLA School of Medicine, where he continues to be a member of the UCLA Evolutionary Medicine Program. In addition to clinical practice, Dr Audeh regularly lectured on the application of Genomics to Cancer Medicine in the UCLA School of Public Health. From 2009 to 2016, Dr. Audeh was a member of the Full Time Academic Faculty of Cedars-Sinai Medical Center. He has been Principal Investigator on many clinical and translational trials, primarily in breast cancer, and was and was instrumental in the early phase trials with PARP inhibitors. Dr Audeh has authored numerous publications in the field of breast cancer, cancer genomics, and genomically targeted cancer therapy. Has also been a consultant to many of the major pharmaceutical and biotech companies, as well as to all genomic testing companies in breast cancer. Dr. Audeh received his medical degree from the University of Iowa and an M.S. Degree in Genetics from the University of Minnesota. He completed Residency in Internal Medicine, a year as Chief Medical Resident, as well as a Fellowship in Medical Oncology at Stanford University Medical Center. He is board certified in internal medicine and medical oncology and is a member of the American Society of Clinical Oncology and the American Association of Cancer Research.
Editor’s Note: This is a letter sent by Dr. Audeh to my sister about her recent book, The First Cell: And the Human Costs of Pursuing Cancer to the Last, and I am publishing it here as a review with his permission. by M. William Audeh May 26, 2020 Dear Azra, I am happy to inform…